Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

Clinical trial NCT07610538 · RECRUITING

Trial details

NCT number: NCT07610538
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease Myocardial Infarction (MI)CABG

Start date: 2026-03-31
Primary completion: 2028-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.